Anita Zahiri , Arash Fereydooni , Emily Eshraghian , Milan Ho , Daniel Delitto , Byrne Lee , George A. Poultsides , Jeffrey A. Norton , E. John Harris , Elizabeth L. George
{"title":"The Two-Decade Experience of Oncovascular Reconstruction in Patients with Retroperitoneal Sarcoma","authors":"Anita Zahiri , Arash Fereydooni , Emily Eshraghian , Milan Ho , Daniel Delitto , Byrne Lee , George A. Poultsides , Jeffrey A. Norton , E. John Harris , Elizabeth L. George","doi":"10.1016/j.avsg.2025.08.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Surgical resection remains the cornerstone of sarcoma treatment; however, tumor involvement of major vasculature presents challenges. Multidisciplinary approaches incorporating vascular surgery have expanded feasibility of resection, yet long-term outcome data remain limited.</div></div><div><h3>Methods</h3><div>We performed a retrospective review of patients with retroperitoneal sarcomas who underwent resection with vascular reconstruction at a tertiary referral center from 2001 to 2024. Data included demographics, tumor characteristics, operative details, and outcomes including mortality, graft patency, and reinterventions.</div></div><div><h3>Results</h3><div>A total of 263 vascular procedures were performed in 101 patients (median age 59 years; 52% female). Prior sarcoma resection occurred in 36.3%, 53.5% received chemoradiation, and 41.7% had stage IV disease. The most common histology was leiomyosarcoma (34.7%). Concurrent procedures included nephrectomy (53.5%) and colectomy (36.3%). Thirty-day mortality was 5%, with a 64.4% Clavien-Dindo grade II + complication rate. Median overall survival was 5.9 years. Vascular reintervention occurred in 11.9% of cases. One-year vascular reintervention-free survival was 90.5%, with no 1-year survival difference between patients with (93.3%, <em>n</em> = 84) and without reconstruction thrombosis (81.7%, <em>n</em> = 16; <em>P</em> = 0.454). Univariate analysis associated thrombosis with diabetes, dual antiplatelet therapy, anticoagulation with antiplatelet therapy, iliac vein reconstruction using cryopreserved grafts, and 90-day readmission. On multivariate analysis, only use of cryopreserved grafts for iliac vein reconstruction remained significantly associated with thrombosis (odds ratio (OR) 12.75, 95% confidence interval (CI) 1.68–18.93; <em>P</em> = 0.019).</div></div><div><h3>Conclusion</h3><div>Over two decades, vascular reconstructions facilitated complex sarcoma resections with favorable long-term outcomes. Iliac vein reconstructions using cryopreserved grafts carry higher thrombosis risk. Despite the complexity of these cases, the outcomes reflect the effectiveness of multidisciplinary management.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"121 ","pages":"Pages 543-554"},"PeriodicalIF":1.6000,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of vascular surgery","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0890509625005564","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Surgical resection remains the cornerstone of sarcoma treatment; however, tumor involvement of major vasculature presents challenges. Multidisciplinary approaches incorporating vascular surgery have expanded feasibility of resection, yet long-term outcome data remain limited.
Methods
We performed a retrospective review of patients with retroperitoneal sarcomas who underwent resection with vascular reconstruction at a tertiary referral center from 2001 to 2024. Data included demographics, tumor characteristics, operative details, and outcomes including mortality, graft patency, and reinterventions.
Results
A total of 263 vascular procedures were performed in 101 patients (median age 59 years; 52% female). Prior sarcoma resection occurred in 36.3%, 53.5% received chemoradiation, and 41.7% had stage IV disease. The most common histology was leiomyosarcoma (34.7%). Concurrent procedures included nephrectomy (53.5%) and colectomy (36.3%). Thirty-day mortality was 5%, with a 64.4% Clavien-Dindo grade II + complication rate. Median overall survival was 5.9 years. Vascular reintervention occurred in 11.9% of cases. One-year vascular reintervention-free survival was 90.5%, with no 1-year survival difference between patients with (93.3%, n = 84) and without reconstruction thrombosis (81.7%, n = 16; P = 0.454). Univariate analysis associated thrombosis with diabetes, dual antiplatelet therapy, anticoagulation with antiplatelet therapy, iliac vein reconstruction using cryopreserved grafts, and 90-day readmission. On multivariate analysis, only use of cryopreserved grafts for iliac vein reconstruction remained significantly associated with thrombosis (odds ratio (OR) 12.75, 95% confidence interval (CI) 1.68–18.93; P = 0.019).
Conclusion
Over two decades, vascular reconstructions facilitated complex sarcoma resections with favorable long-term outcomes. Iliac vein reconstructions using cryopreserved grafts carry higher thrombosis risk. Despite the complexity of these cases, the outcomes reflect the effectiveness of multidisciplinary management.
手术切除仍然是肉瘤治疗的基石;然而,肿瘤累及主要的脉管系统提出了挑战。结合血管手术的多学科方法扩大了切除的可行性,但长期结果数据仍然有限。方法:我们对2001年至2024年在三级转诊中心接受切除血管重建的腹膜后肉瘤患者进行了回顾性研究。数据包括人口统计学、肿瘤特征、手术细节和结果,包括死亡率、移植物通畅和再干预。结果:101例患者(中位年龄59岁,52%为女性)共行263例血管手术。先前的肉瘤切除术发生率为36.3%,53.5%接受过放化疗,41.7%为IV期疾病。最常见的组织学为平滑肌肉瘤(34.7%)。同期手术包括肾切除术(53.5%)和结肠切除术(36.3%)。30天死亡率为5%,Clavien-Dindo II+级并发症发生率为64.4%。中位总生存期为5.9年。11.9%发生血管再介入。无血管再干预患者1年生存率为90.5%,无重建血栓患者(93.3%,n=84)与无重建血栓患者(81.7%,n=16; P=0.454)的1年生存率无差异。单因素分析与血栓形成与糖尿病、双重抗血小板治疗、抗凝与抗血小板治疗、髂静脉重建使用低温保存的移植物和90天再入院相关。在多因素分析中,仅使用冷冻保存的移植物重建髂静脉仍与血栓形成显著相关(OR 12.75, 95% CI 1.68-18.93; P = 0.019)。结论:在过去的二十年中,血管重建促进了复杂肉瘤的切除,并具有良好的长期预后。髂静脉重建采用低温保存的移植物具有较高的血栓形成风险。尽管这些病例很复杂,但结果反映了多学科管理的有效性。
期刊介绍:
Annals of Vascular Surgery, published eight times a year, invites original manuscripts reporting clinical and experimental work in vascular surgery for peer review. Articles may be submitted for the following sections of the journal:
Clinical Research (reports of clinical series, new drug or medical device trials)
Basic Science Research (new investigations, experimental work)
Case Reports (reports on a limited series of patients)
General Reviews (scholarly review of the existing literature on a relevant topic)
Developments in Endovascular and Endoscopic Surgery
Selected Techniques (technical maneuvers)
Historical Notes (interesting vignettes from the early days of vascular surgery)
Editorials/Correspondence